Advances in the understanding and treatment of sepsis-induced immunosuppression

F Venet, G Monneret - Nature Reviews Nephrology, 2018 - nature.com
Sepsis is defined as a life-threatening organ dysfunction that is caused by a dysregulated
host response to infection. Sepsis can induce acute kidney injury and multiple organ failures …

Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation

A Raheem, L Liang, G Zhang, S Cui - Frontiers in immunology, 2021 - frontiersin.org
In order to inhibit pathogenic complications and to enhance animal and poultry growth,
antibiotics have been extensively used for many years. Antibiotics applications not only …

[HTML][HTML] Monoclonal antibody as a potential anti-COVID-19

L Jahanshahlu, N Rezaei - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is expanding rapidly, which made it as one
of top priorities for scientists to develop novel treatment strategies. Researchers are racing to …

Myeloid cells in sepsis‐acquired immunodeficiency

F Venet, J Demaret, M Gossez… - Annals of the New York …, 2021 - Wiley Online Library
Abstract On May 2017, the World Health Organization recognized sepsis as a global health
priority. Sepsis profoundly perturbs immune homeostasis by initiating a complex response …

Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments

R Akter, MH Rahman, T Bhattacharya… - … Science and Pollution …, 2021 - Springer
In the light of thousands of infections and deaths, the World Health Organization (WHO) has
declared the outbreak of coronavirus disease (COVID-19) a worldwide pandemic. It has …

Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses

AC Liu, K Patel, RD Vunikili, KW Johnson… - Briefings in …, 2020 - academic.oup.com
Sepsis is a series of clinical syndromes caused by the immunological response to infection.
The clinical evidence for sepsis could typically attribute to bacterial infection or bacterial …

COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy

MH Rahman, R Akter, T Behl… - Current …, 2020 - ingentaconnect.com
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As
there is no defensive immunity in humans and a virus can overcome inborn immune …

A review on currently available potential therapeutic options for COVID-19

S Ohadian Moghadam - International Journal of General Medicine, 2020 - Taylor & Francis
A series of unexplained pneumonia cases currently were first reported in December 2019 in
Wuhan, China. Official names have been announced for the virus responsible, previously …

[图书][B] Coronavirus disease 2019 (COVID-19): origin, impact, and drug development

A Mishra, N Nair, AK Yadav, P Solanki, J Majeed… - 2021 - books.google.com
At the end of December 2019, in Wuhan, China, a rapidly spreading unknown virus was
reported to have caused coronavirus disease of 2019 (COVID-19). Origin linked to Wuhan's …

Antimicrobial immunotherapeutics: past, present and future

DK Mercer, ML Francis… - Emerging Topics in Life …, 2021 - portlandpress.com
In this age of antimicrobial resistance (AMR) there is an urgent need for novel antimicrobials.
One area of recent interest is in developing antimicrobial effector molecules, and even cell …